|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07K 16/28 | |
| C12N 15/63 | |||
| A61K 39/395 | |||
| A61K 47/48 | |||
| A61K 51/10 | |||
| C12N 5/10 |
| (11) | Patento numeris | 2330130 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10013084.8 |
| Europos patento paraiškos padavimo data | 2003-10-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-06-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-08-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 419163 P | 2002-10-17 | US | |
| 460028 P | 2003-04-02 | US |
| (72) |
Teeling, Jessica, GB
Ruuls, Sigrid, NL
Glennie, Martin, GB
Van De Winkel, Jan G.J., NL
Parren, Paul, NL
Petersen, Jorgen, DK
Baadsgaard, Ole D.M. Sc., DK
Huang, Haichun, US
|
| (73) |
Genmab A/S,
Bredgade 34 E, 1260 Copenhagen K,
DK
|
| (54) | Human monoclonal antibodies against CD20 |
| Human monoclonal antibodies against CD20 |